
AGILON HEALTH INC
AGLNYSE🏆 #1636 by market capEarnings Nov 2US Equity
$644.95▲ $26.83 (+4.16%)
Simulated price1h—
24h▲ 4.2%
7d—
14d—
30d—
1y—
🏦Market Cap
$1.63B
Small Cap
📈Revenue Growth (YoY)
+0.3%
Slowing
📊Gross Margin
3.8%
Thin
💵FCF Margin
—
⚖️P/S Ratio
0.3x
Cheap
Otter Score
64
Fair
📊
Analyst Ratings
Price
$644.95
Total
25
Raised
2
Lowered
6
Avg PT
$125.20
| Institution | Action | Rating | Date |
|---|---|---|---|
Benchmark | Reiterated | Buy | 2026-08-06 |
Evercore ISI Group | Reiterated | In Line | 2026-08-06 |
Barclays | Reiterated | Equal Weight | 2026-08-06 |
Truist Securities | Reiterated | Hold | 2026-08-06 |
Citigroup | Downgraded | Neutral → Sell | 2026-07-23 |
Wells Fargo | Reiterated | Overweight | 2026-07-13 |
TD Cowen | Reiterated | Hold | 2026-05-11 |
Jefferies | Upgraded | Hold → Buy | 2026-05-07 |
Deutsche Bank | Upgraded | Hold → Buy | 2026-05-07 |
Baird | Reiterated | Neutral | 2026-05-07 |
JP Morgan | Downgraded | Neutral → Underweight | 2026-05-04 |
Bernstein | Downgraded | Outperform → Market Perform | 2025-08-20 |
Goldman Sachs | Reiterated | Neutral | 2025-05-08 |
JMP Securities | Reiterated | Market Perform | 2025-04-28 |
Needham | Reiterated | Hold | 2025-03-21 |
Citizens Capital Markets | Reiterated | Market Perform | 2025-02-26 |
Stifel | Reiterated | Hold | 2025-02-26 |
RBC Capital | Reiterated | Outperform | 2025-02-26 |
William Blair | Downgraded | Outperform → Market Perform | 2024-11-08 |
B of A Securities | Downgraded | Buy → Underperform | 2024-10-02 |
Wolfe Research | Downgraded | Outperform → Peer Perform | 2024-01-08 |
Guggenheim | Reiterated | Buy | 2023-03-06 |
SVB Leerink | Reiterated | Outperform | 2022-11-04 |
BTIG | Reiterated | Neutral | 2022-06-24 |
Cowen & Co. | Reiterated | Outperform | 2021-09-10 |
One row per institution, most recent rating